Home/Filings/4/0001578563-24-000202
4//SEC Filing

D'Adamio Anthony 4

Accession 0001578563-24-000202

CIK 0001665988other

Filed

Apr 14, 8:00 PM ET

Accepted

Apr 15, 6:00 PM ET

Size

5.4 KB

Accession

0001578563-24-000202

Insider Transaction Report

Form 4
Period: 2024-04-11
D'Adamio Anthony
SVP & General Counsel
Transactions
  • Sale

    Class A Common Stock

    2024-04-11$4.75/sh3,054$14,50758,242 total
Footnotes (2)
  • [F1]Reflects shares sold to cover taxes upon the vesting of restricted stock units on April 10, 2024 pursuant to a standing 10b5-1 instruction adopted on April 10, 2023.
  • [F2]The price reported in Column 4 is a weighted average price calculated by the broker executing the sales transactions. These shares were sold as part of a trade comprised of shares of multiple employees of the Issuer in multiple transactions at prices ranging from $4.53 to $4.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the aggregate number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Bioventus Inc.

CIK 0001665988

Entity typeother

Related Parties

1
  • filerCIK 0001835184

Filing Metadata

Form type
4
Filed
Apr 14, 8:00 PM ET
Accepted
Apr 15, 6:00 PM ET
Size
5.4 KB